Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Amenamevir in Healthy Males
NCT02852876Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Amenamevir in genital herpes and herpes zoster (HZ) (11 arms), sponsored by Astellas Pharma. Primary endpoints: Safety and tolerability assessed by nature, frequency, and severity of Adverse Events, Safety assessed by 12-lead electrocardiogram and 3 more. Started Sep 2005; status: completed.
02
Drugs
Amenamevir
03
Conditions
genital herpesherpes zoster (HZ)
Beyond the preview
Go deeper on NCT02852876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02852876.